Status of the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway in liver and skin of the freeze tolerant wood frog

被引:1
|
作者
Douglas, Kurtis
Logan, Samantha M.
Storey, Kenneth B. [1 ]
机构
[1] Carleton Univ, Inst Biochem, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Anti-apoptosis; Rana sylvatica; JAK-STAT; Freeze survival; Frozen liver; Frozen skin; RANA-SYLVATICA; HIBERNATION; GENES;
D O I
10.1016/j.cryobiol.2022.08.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The wood frog (Rana sylvatica) has adapted full-body freezing and thawing as a means of sub-zero winter survival and early-breeding in ephemeral pools. One such protective process implicated recently in freeze-thaw tolerance is that of anti-apoptotic signaling, which has been proposed to play a cytoprotective role by modulating stress -induced death signals. This study employed the use of immunoblotting to examine response of a potent cell cycle and apoptosis regulator, known as the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, to freezing and thawing in the liver and skin of the wood frog. This pathway demonstrably exhibits factor-and tissue-specific changes between non-frozen, 24 h-frozen, and 8 h-thawed conditions. There were few changes in JAK-STAT proteins in frozen frogs, but protective changes were observed upon thaw: Elevated levels of pJAK3 and nuclear localization of pSTAT3 and pSTAT5 suggested an increase in anti-apoptotic signaling after thaw. By contrast, both STAT1 and STAT3 signaling appeared to increase in frozen skin, sug-gesting frogs use homeostatic regulation of apoptotic-and anti-apoptotic signals, in an antagonistic and compensatory manner. As such, these findings support that JAK-STAT pathway signaling modulation is a plausible adaptation that contributes to fast and reversible manipulation of anti-apoptotic signals, thus assisting in freeze survival of the wood frog.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 50 条
  • [1] Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway
    Park, ES
    Kim, H
    Suh, JM
    Park, SJ
    You, SH
    Chung, HK
    Lee, KW
    Kwon, OY
    Cho, BY
    Kim, YK
    Ro, HK
    Chung, J
    Shong, M
    MOLECULAR ENDOCRINOLOGY, 2000, 14 (05) : 662 - 670
  • [2] FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
    Potlabathini, Tejaswini
    Pothacamuri, Mounica A.
    Bandi, Venkata Varshitha
    Anjum, Mahnoor
    Shah, Parmendra
    Molina, M.
    Dutta, Nilashis
    Adzhymuratov, Oleksandr
    Mathew, Midhun
    Sadu, Vatsalya
    Zahid, Shiza A.
    Lingamgunta, Harini
    Sahotra, Monika
    Nasiri, Syed Muhammad Zain Jamil
    Daguipa, Christine Dawn M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [3] Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway
    Himpe, Eddy
    Kooijman, Ron
    BIOFACTORS, 2009, 35 (01) : 76 - 81
  • [4] The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors
    Zhao, Ruihong
    Hu, Zhangmin
    Zhang, Xiaoli
    Huang, Shujuan
    Yu, Guodong
    Wu, Zhe
    Yu, Wei
    Lu, Juan
    Ruan, Bing
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [5] The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors
    Ruihong Zhao
    Zhangmin Hu
    Xiaoli Zhang
    Shujuan Huang
    Guodong Yu
    Zhe Wu
    Wei Yu
    Juan Lu
    Bing Ruan
    Cell Communication and Signaling, 22
  • [6] Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo
    Mohan, Chakrabhavi Dhananjaya
    Bharathkumar, Hanumantharayappa
    Bulusu, Krishna C.
    Pandey, Vijay
    Rangappa, Shobith
    Fuchs, Julian E.
    Shanmugam, Muthu K.
    Dai, Xiaoyun
    Li, Feng
    Deivasigamani, Amudha
    Hui, Kam M.
    Kumar, Alan Prem
    Lobie, Peter E.
    Bender, Andreas
    Basappa
    Sethi, Gautam
    Rangappa, Kanchugarakoppal S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (49) : 34296 - 34307
  • [7] Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer
    Rizwi, Fahim Anwar
    Abubakar, Md.
    Puppala, Eswara Rao
    Goyal, Ahsas
    Bhadrawamy, Ch. Veera
    Naidu, V. G. M.
    Roshan, S.
    Tazneem, B.
    Almalki, Waleed Hassan
    Subramaniyan, Vetriselvan
    Rawat, Sushama
    Guptah, Gaurav
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2023, 42 (04) : 15 - 29
  • [8] Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
    Berthier, Celine C.
    Zhang, Hongyru
    Schin, MaryLee
    Henger, Anna
    Nelson, Robert G.
    Yee, Berne
    Boucherot, Anissa
    Neusser, Matthias A.
    Cohen, Clemens D.
    Carter-Su, Christin
    Argetsinger, Lawrence S.
    Rastaldi, Maria P.
    Brosius, Frank C.
    Kretzler, Matthias
    DIABETES, 2009, 58 (02) : 469 - 477
  • [9] Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
    Panipinto, Paul M.
    Singh, Anil K.
    Shaikh, Farheen S.
    Siegel, Ruby J.
    Chourasia, Mukesh
    Ahmed, Salahuddin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [10] The activities of the Janus kinase-Signal transduction and activator of transcription (Jak-STAT) pathway and the extracellular-regulated protein kinase (ERK) pathway determine IFN-response in renal cancer cells.
    Song, MM
    Wi, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : A31 - A31